Patents Assigned to University of Limburg
  • Patent number: 5800981
    Abstract: A combined antigen having at least three portions of human cytomegalovirus (HCMV) proteins and characterized by an enhanced ability to bind HCMV-specific antibodies, for use in assays for the detection of HCMV-specific antibodies and as a vaccine to confer protective immunity against HCMV-mediated diseases.
    Type: Grant
    Filed: February 22, 1996
    Date of Patent: September 1, 1998
    Assignee: University of Limburg
    Inventors: Catharina A. Bruggeman, Cornelis Vink, Albert Ramon, Frans Stals